Theracryf Plc
Theracryf Plc, a clinical stage therapeutics company, engages in the development of therapeutics for oncology and behavioural brain disorders. The company develops orexin-1 antagonist for the treatment of binge eating disorder and anxiety; and atypical dopamine transporter inhibitor (DAT) to treat fatigue and narcolepsy. It also develops SFX-01 for the treatment of brain cancer glioblastoma and n… Read more
Theracryf Plc (TCF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.146x
Based on the latest financial reports, Theracryf Plc (TCF) has a cash flow conversion efficiency ratio of -0.146x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-699.00K) by net assets (GBX4.80 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Theracryf Plc - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Theracryf Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Theracryf Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Theracryf Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Reem Capital Corp.
V:REEM-P
|
-0.390x |
|
Neovacs S.A.
PA:ALNEV
|
-0.129x |
|
Biztech Konsulting SA
WAR:BTK
|
N/A |
|
Restart Life Sciences Corp.
PINK:NMLSD
|
-1.238x |
|
Intermarket Sec.
KAR:IMS
|
N/A |
|
CANADA ZINC METALS
MU:M9R
|
-0.006x |
|
Mahanna Islamic Inde
KAR:MIIETF
|
N/A |
|
SOLOMON SYSTECH
MU:RZF
|
N/A |
Annual Cash Flow Conversion Efficiency for Theracryf Plc (2017–2025)
The table below shows the annual cash flow conversion efficiency of Theracryf Plc from 2017 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | GBX5.97 Million | GBX-2.37 Million | -0.397x | +69.01% |
| 2024-03-31 | GBX2.34 Million | GBX-3.00 Million | -1.280x | -69.65% |
| 2023-03-31 | GBX5.34 Million | GBX-4.03 Million | -0.754x | -171.89% |
| 2022-03-31 | GBX9.23 Million | GBX-2.56 Million | -0.277x | -11.99% |
| 2021-03-31 | GBX11.81 Million | GBX-2.93 Million | -0.248x | +59.57% |
| 2020-03-31 | GBX4.20 Million | GBX-2.58 Million | -0.613x | +44.38% |
| 2019-03-31 | GBX2.08 Million | GBX-2.29 Million | -1.102x | -82.16% |
| 2018-03-31 | GBX3.87 Million | GBX-2.34 Million | -0.605x | +19.87% |
| 2017-03-31 | GBX4.23 Million | GBX-3.19 Million | -0.755x | -- |